297 related articles for article (PubMed ID: 20833746)
1. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.
Malathi K; Saito T; Crochet N; Barton DJ; Gale M; Silverman RH
RNA; 2010 Nov; 16(11):2108-19. PubMed ID: 20833746
[TBL] [Abstract][Full Text] [Related]
2. Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.
Schnell G; Loo YM; Marcotrigiano J; Gale M
PLoS Pathog; 2012; 8(8):e1002839. PubMed ID: 22912574
[TBL] [Abstract][Full Text] [Related]
3. RNase L Amplifies Interferon Signaling by Inducing Protein Kinase R-Mediated Antiviral Stress Granules.
Manivannan P; Siddiqui MA; Malathi K
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295917
[TBL] [Abstract][Full Text] [Related]
4. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA.
Saito T; Owen DM; Jiang F; Marcotrigiano J; Gale M
Nature; 2008 Jul; 454(7203):523-7. PubMed ID: 18548002
[TBL] [Abstract][Full Text] [Related]
5. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
6. Small self-RNA generated by RNase L amplifies antiviral innate immunity.
Malathi K; Dong B; Gale M; Silverman RH
Nature; 2007 Aug; 448(7155):816-9. PubMed ID: 17653195
[TBL] [Abstract][Full Text] [Related]
7. Links between recognition and degradation of cytoplasmic viral RNA in innate immune response.
Oshiumi H; Mifsud EJ; Daito T
Rev Med Virol; 2016 Mar; 26(2):90-101. PubMed ID: 26643446
[TBL] [Abstract][Full Text] [Related]
8. New insights into the role of RNase L in innate immunity.
Chakrabarti A; Jha BK; Silverman RH
J Interferon Cytokine Res; 2011 Jan; 31(1):49-57. PubMed ID: 21190483
[TBL] [Abstract][Full Text] [Related]
9. RNase L and the NLRP3-inflammasome: An old merchant in a new trade.
Banerjee S
Cytokine Growth Factor Rev; 2016 Jun; 29():63-70. PubMed ID: 26987611
[TBL] [Abstract][Full Text] [Related]
10. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
[TBL] [Abstract][Full Text] [Related]
11. RNA PAMPs as Molecular Tools for Evaluating RIG-I Function in Innate Immunity.
Ireton RC; Wilkins C; Gale M
Methods Mol Biol; 2017; 1656():119-129. PubMed ID: 28808965
[TBL] [Abstract][Full Text] [Related]
12. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
13. RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling.
Durbin AF; Wang C; Marcotrigiano J; Gehrke L
mBio; 2016 Sep; 7(5):. PubMed ID: 27651356
[TBL] [Abstract][Full Text] [Related]
14. [Innate immune response to RNA virus infection].
Oshiumi H; Matsumoto M; Seya T
Uirusu; 2011 Dec; 61(2):153-61. PubMed ID: 22916562
[TBL] [Abstract][Full Text] [Related]
15. Cell-type-specific effects of RNase L on viral induction of beta interferon.
Banerjee S; Chakrabarti A; Jha BK; Weiss SR; Silverman RH
mBio; 2014 Feb; 5(2):e00856-14. PubMed ID: 24570368
[TBL] [Abstract][Full Text] [Related]
16. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the transcription factor Sp1 activates the OAS-RNAse L-RIG-I pathway.
Dupuis-Maurin V; Brinza L; Baguet J; Plantamura E; Schicklin S; Chambion S; Macari C; Tomkowiak M; Deniaud E; Leverrier Y; Marvel J; Michallet MC
PLoS One; 2015; 10(3):e0118551. PubMed ID: 25738304
[TBL] [Abstract][Full Text] [Related]
18. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.
Saito T; Hirai R; Loo YM; Owen D; Johnson CL; Sinha SC; Akira S; Fujita T; Gale M
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):582-7. PubMed ID: 17190814
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities.
Uzri D; Gehrke L
J Virol; 2009 May; 83(9):4174-84. PubMed ID: 19224987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
